WallStreetZenWallStreetZen

NASDAQ: CLDX
Celldex Therapeutics Revenue

Celldex Therapeutics revenue was $8.30M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2024) ending on Jun 30, 2024 was $2.5M, up 1,501.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CLDX annual revenue was $6.9M, with 192% growth year-over-year.

CLDX past revenue growth

How has CLDX's revenue growth performed historically?
Company
155.05%
Industry
97.42%
Market
19.47%
CLDX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CLDX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CLDX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CLDX revenue history

Current Revenue
$8.3M
Current Earnings
-$150.2M
Current Profit Margin
-1,809.4%

Be the first to know when CLDX announces revenue.

CLDX Revenue History By Year

CLDX Yearly RevenueCLDX RevenueCLDX ChangeCLDX Revenue Growth
2023-12-31$6.88M$4.53M+192.02%
2022-12-31$2.36M-$2.29M-49.32%
2021-12-31$4.65M-$2.77M-37.30%
2020-12-31$7.42M$3.85M+107.61%
2019-12-31$3.57M-$5.97M-62.54%
2018-12-31$9.54M-$3.21M-25.15%
2017-12-31$12.74M$5.96M+87.78%
2016-12-31$6.79M$1.31M+23.83%
2015-12-31$5.48M$1.89M+52.82%
2014-12-31$3.59M-$525.00k-12.77%
2013-12-31$4.11M-$7.09M-63.30%
2012-12-31$11.20M$1.94M+20.91%
2011-12-31$9.27M-$37.53M-80.20%
2010-12-31$46.79M$31.61M+208.25%
2009-12-31$15.18M$7.72M+103.59%
2008-12-31$7.46M$6.05M+430.30%
2007-12-31$1.41M$506.82k+56.36%
2006-12-31$899.18k-$2.19M-70.88%
2005-12-31$3.09M-$3.77M-54.97%
2004-12-31$6.86M$2.23M+48.04%
2003-12-31$4.63M-$2.07M-30.90%
2002-12-31$6.70M$3.36M+100.39%
2001-12-31$3.35M$2.58M+338.40%
2000-12-31$763.20k-$720.30k-48.55%
1999-12-31$1.48M-$666.90k-31.01%
1998-12-31$2.15M$958.30k+80.39%
1997-12-31$1.19M$77.60k+6.96%
1996-12-31$1.11M-$2.85M-71.88%
1995-12-31$3.96M-$3.00M-43.12%
1994-12-31$6.97MN/AN/A

1 of 2

Celldex Therapeutics Revenue FAQ

What was CLDX's revenue last quarter?

On Invalid Date, Celldex Therapeutics (NASDAQ: CLDX) reported Q2 2024 revenue of $2.50 million up 832.09% year over year. In the same quarter last year, Celldex Therapeutics's revenue was $268.00 thousand.

What was Celldex Therapeutics's revenue in 2023?

Celldex Therapeutics's annual revenue for the twelve months ending Dec 31, 2023 was $6.88 million, a 192.02% increase year over year.

How much does Celldex Therapeutics make in a day?

Based on Celldex Therapeutics annual revenue for the past five years, CLDX makes an average of $13,633.97 per day.

What was Celldex Therapeutics's annual revenue growth in the past year?

As of Q4 2024, Celldex Therapeutics's revenue has grown 155.05% year over year. This is 57.64 percentage points higher than the US Biotechnology industry revenue growth rate of 97.42%. Celldex Therapeutics's revenue in the past year totaled $8.30 million.

How much does Celldex Therapeutics make in a year?

Celldex Therapeutics's revenue by year for the past five years is:
  • Celldex Therapeutics's revenue for the twelve months ending Dec 31, 2023 was $6.88 million, a 192.02% increase year over year.
  • Celldex Therapeutics's annual revenue for Dec 31, 2022 was $2.36 million, a 49.32% decrease from 2021.
  • Celldex Therapeutics's annual revenue for 2021 was $4.65 million, a 37.3% decrease from 2020.
  • Celldex Therapeutics's annual revenue for 2020 was $7.42 million, a 107.61% increase from 2019.
  • Celldex Therapeutics's annual revenue for 2019 was $3.57 million, a 62.54% decrease from 2018.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.